Tumor-infiltrating T cells may be markers to predict patients’ responses to cancer immunotherapy

New insights into a population of tumor-infiltrating T cells may ultimately allow doctors to predict how patients will respond to checkpoint blockade immunotherapy, a form of cancer treatment with advantages that doctors say could benefit a wider patient population.

Leave A Comment

Your email address will not be published. Required fields are marked *